Inhalation of a new anticholinergic drug, SCH 1000, in asthma and chronic bronchitis: effect on airway resistance, thoracic gas volume, blood gases and exercise-induced asthma.
D000293:Adolescent; D000328:Adult; D000336:Aerosols; D000368:Aged; D000403:Airway Resistance / Q000187:drug effects; D001249:Asthma / Q000188:drug therapy*; D001285:Atropine / Q000627:therapeutic use*; D001784:Blood Gas Analysis; D001991:Bronchitis / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002245:Carbon Dioxide / Q000097:blood; D002908:Chronic Disease; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007545:Isoproterenol / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010100:Oxygen / Q000097:blood; D010276:Parasympatholytics / Q000627:therapeutic use*; D011407:Propane / Q000627:therapeutic use
D000336:Aerosols; D001993:Bronchodilator Agents; D010276:Parasympatholytics; D002245:Carbon Dioxide; D001285:Atropine; D007545:Isoproterenol; D010100:Oxygen; D011407:Propane